Genprex stock plunges to 52-week low of $1.38 amid market challenges
Genprex Inc. (NASDAQ:) shares tumbled to a 52-week low, touching down at $1.38 as the...
Genprex Inc. (NASDAQ:) shares tumbled to a 52-week low, touching down at $1.38 as the...
Andrew Peller Limited (ADW.A/ADW.B), a leading Canadian winemaker, reported a slight decline in sales in...
WATERLOO, Ontario – eSentire, a prominent Managed Detection and Response (MDR) provider, has announced the...
Competing with the duopoly that dominates the stablecoin market won't be easy for Ripple's new coin on the block.
The New York Fed survey showed that expectations for what inflation will be in three years dropped to 2.3%, the lowest since the survey began in 2013.
Critics have ridiculed the 21-year-old’s new product “Friend,” but Schiffmann remains unfazed.
Jefferies has adjusted its price target for Amphastar Pharmaceuticals (NASDAQ: NASDAQ:), a company specializing in...
By Maytaal Angel JERUSALEM (Reuters) – Israeli Prime Minister Benjamin Netanyahu traded barbs with his...
BMO Capital Markets has maintained its Market Perform rating on Boise Cascade Company (NYSE: NYSE:)...